Alexion is a global biopharmaceutical company focused on developing and delivering life-changing therapies for patients with devastating and rare diseases. Patients with these life-threatening diseases often have no effective treatment options, and they and their families suffer with little hope. Our goal is to deliver medical breakthroughs where none currently exist. We are driven because we know people's lives depend on our work.
Alexion was established in the U.S. in 1992 and became a public company in 1996 (NASDAQ: ALXN). Alexion's employees around the world serve patients in approximately 50 countries. Our ambition is to be the global leader in rare diseases by leveraging our 20+ years of expertise in complement biology and our capabilities in hematology, nephrology, neurology and metabolic disorders to bring additional life-changing therapies to patients.
MCPHS University provides an academic environment to guide and support fellows toward a successful career in the biopharmaceutical industry. As a private institution with a history of specializing in health sciences, MCPHS University offers programs that embody scholarship, professional service, and community outreach
....
Through MCPHS University, the fellow will have the opportunity to gain teaching and research experience in an academic setting. MCPHS University faculty and company program leaders mentor fellows according to their scholarly and professional interests throughout the two-year program.
As an adjunct instructor at MCPHS, the fellow may have the opportunity to:
• Develop, coordinate, and teach courses
• Co-precept pharmacy students on advanced experiential rotations
• Create and publish scholarly research and/or review articles
• Present research at scientific and clinical meetings
• Participate in professional development seminars with other fellows and residents from MCPHS-affiliated programs
Show more
Show less
